Elsevier

Medical Hypotheses

Volume 146, January 2021, 110464
Medical Hypotheses

Correspondence
Closing the portal to SARS-CoV-2 cellular entry: May open newer avenues

https://doi.org/10.1016/j.mehy.2020.110464Get rights and content

Keywords

Camostat mesylate
Cellular entry
COVID-19
Nafamostat mesylate
SARS-CoV-2 pneumonia
Thrombosis
Transmembrane protease serine 2 (TMPRSS2)

Cited by (0)

View Abstract